Research to develop therapy for ischemic disease from basic research to translational research

被引:0
|
作者
Kasai, Atsushi [1 ]
Shintani, Norihito [2 ]
Kato, Hideaki [2 ]
Kakuda, Michiya [3 ]
Gomi, Fumi [4 ]
Tano, Yasuo [4 ]
Hashimoto, Hitoshi [2 ,3 ]
Maeda, Sadaaki [1 ]
Baba, Akemichi [2 ]
机构
[1] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacotherapeut, Osaka, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 565, Japan
[3] Osaka Univ, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Suita, Osaka 565, Japan
[4] Osaka Univ, Grad Sch Med, Suita, Osaka 565, Japan
关键词
apelin; angiogenesis; ischemic disease; FGF2; VEGF;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apelin is an endogenous ligand for the G-protein-coupled receptor, APJ, and participates in multiple physiological processes. To identify the roles of endogenous apelin, we investigated the phenotype of apelin-deficient (apelin-KO) mice. Apelin-KO mice showed significantly impaired retinal vascularization in the early postnatal period. Retinal apelin/APJ mRNAs were transiently upregulated during the first 2 postnatal weeks but were undetectable in adults. There were no differences in VEGF or FGF2 mRNA expression, or in the morphology and localization of GFAP-positive astrocytes, in the apelin-KO retinas at P5. The corneal pocket assay showed that angiogenic responses to VEGF and FGF2 were remarkably decreased in apelin-KO mice. The reduced responses to VEGF and FGF2 in apelin-KO mice were partially restored by apelin, but apelin alone did not induce angiogenesis. Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF and/or FGF2.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条